BLOG

Nurix eligible for $2.5B in milestone payments in Sanofi deal

Nurix Therapeutics Inc. landed its second big pharma collaboration in seven months when it signed with Sanofi SA to discover, develop and commercialize a pipeline of protein degradation therapies.